USPTO serial 79446283
Serial No. 79446283
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- GULIANO, ROBERT N
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79446283?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Zaccaria
John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietetic foods adapted for medical purposes; teeth filling material; herbicides; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; pharmaceutical preparations for the treatment of neuroendocrine disorders; fungicides; food for babies; dietetic substances in the nature of dietetic foods adapted for medical use; disinfectants; nutritional supplements for medical purposes; homogenized food adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; Food supplements, namely, anti-oxidants; dietetic beverages adapted for medical purposes; vitamin supplement patches; dietary fibre supplements; glycerine for medical purposes; immunostimulants; protein dietary supplements; mineral dietary supplements; dietary supplements for human beings; medicated lotions for pharmaceutical purposes; narcotics being pharmaceuticals for the treatment of pain; opiates being pharmaceuticals for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of cancer; Pharmaceutical preparations in the form of pastilles for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; Pharmaceutical preparations in the form of pastilles for the treatment of neuroendocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes for the treatment of pain; chemical preparations for pharmaceutical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for pharmaceutical purposes for the treatment of neuroendocrine disorders; chemical preparations for medical purposes for the treatment of cancer; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of neuroendocrine disorders; Aloe vera preparations for pharmaceutical purposes; phytotherapy preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer-related conditions; vitamin preparations; chemico-pharmaceutical preparations for the treatment of cancer; chemico-pharmaceutical preparations for the treatment of pain; chemico-pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemico-pharmaceutical preparations for the treatment of neuroendocrine disorders | ACTIVE | — |
| 035 | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; advertising services | ACTIVE | — |
| 041 | Arranging and conducting of in-person educational forums in the field of pharmaceuticals; Educational services in the nature of pharmaceuticals schools; providing information in the field of education; providing online electronic publications, not downloadable, namely, brochures in the field of pharmaceuticals; arranging and conducting of conferences in the field of pharmaceuticals; arranging and conducting of congresses in the field of pharmaceuticals; arranging and conducting of colloquiums in the field of pharmaceuticals; arranging and conducting of seminars in the field of pharmaceuticals; arranging and conducting of symposiums in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MEDIOLANUM FARMACEUTICI S.p.A.
- Other trademarks owned by MEDIOLANUM FARMACEUTICI S.p.A.
- Other trademarks owned by MEDIOLANUM FARMACEUTICI S.p.A.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 041
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 22, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 22, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 22, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 21, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 21, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |